N. Suzuki

发表

8-1A, a human monoclonal antibody that reacts with intact human chorionic gonadotropin.

I. Ishida, D. Aoki, N. Susumu, 2006, Placenta.

Immunofluorescence-Detected Infiltration of CD4+FOXP3+ Regulatory T Cells is Relevant to the Prognosis of Patients With Endometrial Cancer

H. Tsuda, D. Aoki, A. Hirasawa, 2011, International Journal of Gynecologic Cancer.

Cell surface expression of hyaluronan on human ovarian cancer cells inversely correlates with their adhesion to peritoneal mesothelial cells

T. Irimura, D. Aoki, H. Takeuchi, 2012, Tumor Biology.

Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer

D. Aoki, N. Susumu, S. Nozawa, 2005, International Journal of Gynecologic Cancer.

Sensitivity to cisplatin determined by the histoculture drug response assay and clinical response of endometrial cancer

D. Aoki, N. Susumu, Y. Udagawa, 2004, International Journal of Gynecologic Cancer.

Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen

I. Ishida, D. Aoki, N. Susumu, 2007, International Journal of Gynecologic Cancer.

HMMC-1

M. Fukuda, I. Ishida, D. Aoki, 2004, Clinical Cancer Research.

HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.

I. Ishida, D. Aoki, N. Susumu, 2004, Gynecologic oncology.

Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: cytoplasmic sequestration of CDK2 by p27.

N. Ueno, J. Kigawa, H. Itamochi, 2011, Gynecologic oncology.

Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma.

D. Aoki, N. Susumu, M. Takao, 2005, Gynecologic oncology.

Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical response

D. Aoki, N. Susumu, Y. Udagawa, 2004, International Journal of Gynecologic Cancer.

Diagnosis of paraaortic and pelvic lymph node metastasis of gynecologic malignant tumors by ultrasound‐guided percutaneous fine‐needle aspiration biopsy

A. Ohara, T. Nakayama, N. Suzuki, 1991, Cancer.

Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary

T. Irimura, D. Aoki, N. Susumu, 2007, Cancer science.

Clinical characteristics of prognostic factors in poorly differentiated (G3) endometrioid adenocarcinoma in Japan.

D. Aoki, N. Susumu, S. Nozawa, 2005, Japanese journal of clinical oncology.

Clinicopathologic manifestations of early‐onset endometrial cancer in Japanese women with a familial predisposition to cancer

D. Aoki, A. Hirasawa, N. Susumu, 2005, The journal of obstetrics and gynaecology research.

Subcellular Localization of Galactosyltransferase Associated with Tumors in Endometrial and Ovarian Cancer Cells

D. Aoki, N. Susumu, S. Nozawa, 2003 .

Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546

D. Aoki, N. Susumu, Y. Udagawa, 2004, International Journal of Gynecologic Cancer.

Overexpression of Class III β-Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma

Y. Oda, M. Kuwano, M. Tsuneyoshi, 2009, Clinical Cancer Research.

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.

A. Okamoto, S. Pignata, Kiyoko Kato, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase III trial of paclitaxel/carboplatin (PC) versus cisplatin/irinotecan (CPT-P) as first-line chemotherapy in patients with clear cell carcinoma (CCC) of the ovary: A Japanese Gynecologic Oncology Group (JGOG)/GCIG study.

A. Okamoto, S. Pignata, Kiyoko Kato, 2014 .

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA)

A. Okamoto, H. Watari, N. Sakuragi, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers

H. Tsuda, D. Aoki, N. Susumu, 2004, International Journal of Gynecologic Cancer.

J. Inazawa, H. Tsuda, D. Aoki, 2004, International Journal of Gynecologic Cancer.

A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: potential new therapy for ovarian clear cell adenocarcinoma.

D. Aoki, N. Susumu, F. Hosoi, 2008, Gynecologic oncology.

A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma.

D. Aoki, N. Susumu, S. Nozawa, 2004, Gynecologic oncology.

Anti-vascular endothelial growth factor receptor 1 antibody as an antagonist for cancer therapy through targeting cancer cells and tumor angiogenesis

I. Ishida, D. Aoki, Yan Wu, 2006 .

Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification.

T. Irimura, D. Aoki, N. Susumu, 2006, Oncology research.

Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancer.

Y. Ohashi, K. Hasegawa, K. Ushijima, 2009, Anticancer research.

The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG

A. Okamoto, T. Enomoto, N. Yaegashi, 2020, Journal of gynecologic oncology.

Establishment and characterization of the RMG-V cell line from human ovarian clear cell adenocarcinoma

D. Aoki, N. Susumu, S. Nozawa, 2008, Human Cell.

Loss of integrin α3 expression is associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells

D. Aoki, N. Susumu, S. Oie, 2008, Human Cell.

A case of pulmonary type of ovarian small cell carcinoma

D. Aoki, N. Susumu, M. Mukai, 2007, The journal of obstetrics and gynaecology research.